CLASS II Device recall · Reported 11 Oct 2017 · FDA Enforcement Report

Human Alpha-1-Antitrypsin Kit recalled by The Binding Site Group

The Binding Site Group is recalling Human Alpha-1-Antitrypsin Kit for use on the SPAPlus analyser, Product #NK034.S. The firm, distributed in California. The recall was initiated on 23 Aug 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #400900, Exp. 12/31/2017, UDI #05051700016421
Quantity recalled361 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0002-2018
FDA event ID
78047
Recalling firm
The Binding Site Group, Birmingham, N/A
Classification
Class II
Status
Terminated
Recall initiated
23 Aug 2017
FDA classified
4 Oct 2017
Reported
11 Oct 2017
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

23 Aug 2017Recall initiated by company
4 Oct 2017Classified by FDA+42 days
11 Oct 2017Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The high control for the kit is recovering low and may be out of range for assigned values.

Product as listed by the FDA

Human Alpha-1-Antitrypsin Kit for use on the SPAPlus analyser, Product #NK034.S. The firm name on the label is The Binding Site Group Ltd., Birmingham, UK. Product is designed for the quantitative in-vitro determination of Alpha-1-antitrypsin in human serum using the SPAPLUS turbidimetric analyser. The measurement of Alpha-1-antitrypsin aids in the diagnosis of several conditions including adult cirrhosis of the liver. In addition, Alpha-1-antitrypsin deficiency has been associated with pulmonary emphysema. This test should be used in conjunction with other laboratory and clinical findings.

Where it was distributed

Worldwide Distribution - US Distribution to the state of CA., and to the countries of : United Kingdom, Germany, France, Czech Republic, Belgium, Panama, Bulgaria, Iran, Argentina, Turkey Romania, Colombia, and Saudi Arabia.

California

Questions about this recall

Why was it recalled?

The high control for the kit is recovering low and may be out of range for assigned values.

Which lots are affected?

Lot #400900, Exp. 12/31/2017, UDI #05051700016421

Where was it sold?

Worldwide Distribution - US Distribution to the state of CA., and to the countries of : United Kingdom, Germany, France, Czech Republic, Belgium, Panama, Bulgaria, Iran, Argentina, Turkey Romania, Colombia, and Saudi Arabia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Other Medical Devices recalls

All 13,950